Boenning & Scattergood’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Boenning & Scattergood's GILD Position: Q4 2022 in Review
Boenning & Scattergood reduced its Gilead Sciences (GILD) stake by 12% in Q4 2022, selling an estimated $41.6K and leaving 3,744 shares worth $223K. The position accounts for 0.04% of the portfolio, ranked #367.
Boenning & Scattergood first reported a position in GILD in Q2 2018 and has held it in 19 quarters since. The position peaked at $2M in Q1 2020. 1,767 funds tracked by Wall St. Rank hold GILD as of Q4 2022.
- Boenning & Scattergood held 3,744 shares of Gilead Sciences worth $223K as of Q4 2022.
- Boenning & Scattergood sold 525 Gilead Sciences shares in Q4 2022, an estimated $41.6K.
- Gilead Sciences made up 0.04% of Boenning & Scattergood's portfolio in Q4 2022, its #367 holding.
- Boenning & Scattergood first reported a position in Gilead Sciences in Q2 2018 and has held it in 19 quarters since.
- Boenning & Scattergood's Gilead Sciences position peaked at $2M in Q1 2020.
- 1,767 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2022.
Based on Boenning & Scattergood's 13F filing for Q4 2022, filed 26 Jan 2023.